Piramal Pharma (NSE:PPLPHARMA) ROE % Adjusted to Book Value : 2.38% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma ROE % Adjusted to Book Value?

Piramal Pharma's ROE % for the quarter that ended in Mar. 2024 was 5.12%. Piramal Pharma's PB Ratio for the quarter that ended in Mar. 2024 was 2.15. Piramal Pharma's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 2.38%.

Piramal Pharma ROE % Adjusted to Book Value Historical Data

The historical data trend for Piramal Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma ROE % Adjusted to Book Value Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

ROE % Adjusted to Book Value

-2.31

0.11

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial							2.47	-	0.15	-	2.38

Competitive Comparison of Piramal Pharma's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Piramal Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Piramal Pharma's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Piramal Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Piramal Pharma's ROE % Adjusted to Book Value falls into.

Piramal Pharma ROE % Adjusted to Book Value Calculation

Piramal Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.24%	/	2.15
	=	0.11%

Piramal Pharma's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	5.12%	/	2.15
	=	2.38%

Piramal Pharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » ROE % Adjusted to Book Value

Traded in Other Exchanges

543635:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines